Literature DB >> 32986349

Cornus Mas L improves Antioxidant Status in the Liver, Lung, Kidney, Testis and Brain of Ehrlich Ascites Tumor Bearing Mice.

Seher Yılmaz1, Ayşe Yeşim Göçmen2, Ersin Karataş3, Adem Tokpınar1.   

Abstract

Cornelian Cherry (Cornus Mas L) has widespread use due to its anti-inflammatory, anti-carcinogenic and anti-oxidant properties. In this study, the effects of Cornus Mas L (C. mas L) in different dosages on the biochemical values of mice organs were investigated in the Ehrlich Ascites tumor model, which originated from mice breast adenocarcinoma and developed in Balb/C mice. In our study, 32 Balb/C type male mice were used. Ehrlich Ascites Tumor (EAT) cells (1x106 EAT cell) from the stock animal were injected into all the mice in an intraperitoneal way. Experimental groups were given 100 and 200mg/kg C. mas L extract intraperitoneally for 9 days. The weights of the animals were recorded every day and were sacrificed on the 9th day. To estimate tumor proliferation of the lung, brain, kidney, liver, and testis, antioxidant parameters were recorded including, the reduced glutathione (GSH), lipid peroxidation, glutathione S-transferase (GST), superoxide dismutase (SOD) and catalase (CAT). Treatments of different doses of C. mas L. meaningfully (p < 0.05) modulated the lung, brain, kidney, liver and testis tissues antioxidant parameters as compared to the control. Our study showed the anti-tumor effect of C. mas L. in assisted tumor development with EAT cells, conceivably moderated by the enhancement of oxidative stress due to numerous mechanisms.<br />.

Entities:  

Keywords:  Antioxidant; Cornus Mas L; Mice; Tumor

Mesh:

Substances:

Year:  2020        PMID: 32986349      PMCID: PMC7779457          DOI: 10.31557/APJCP.2020.21.9.2531

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  23 in total

Review 1.  Angiogenesis.

Authors:  J Folkman; Y Shing
Journal:  J Biol Chem       Date:  1992-06-05       Impact factor: 5.157

2.  Reversible G2 block in the cell cycle of Ehrlich ascites carcinoma cells.

Authors:  Y A Lazebnik; N D Medvedeva; V V Zenin
Journal:  Exp Cell Res       Date:  1991-07       Impact factor: 3.905

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  A new automated colorimetric method for measuring total oxidant status.

Authors:  Ozcan Erel
Journal:  Clin Biochem       Date:  2005-10-07       Impact factor: 3.281

5.  Serum total oxidant/antioxidant status and trace element levels in breast cancer patients.

Authors:  Jia-Fu Feng; Ling Lu; Ping Zeng; Yun-Hong Yang; Jun Luo; Yu-Wei Yang; Dong Wang
Journal:  Int J Clin Oncol       Date:  2011-10-05       Impact factor: 3.402

Review 6.  Cancer as an evolutionary and ecological process.

Authors:  Lauren M F Merlo; John W Pepper; Brian J Reid; Carlo C Maley
Journal:  Nat Rev Cancer       Date:  2006-11-16       Impact factor: 60.716

7.  Curcumin ameliorates cisplatin-induced nephrotoxicity by inhibiting renal inflammation in mice.

Authors:  Masaaki Ueki; Masaki Ueno; Jun Morishita; Nobuhiro Maekawa
Journal:  J Biosci Bioeng       Date:  2012-12-13       Impact factor: 2.894

8.  In vitro cytotoxic and antioxidative activity of Cornus mas and Cotinus coggygria.

Authors:  Katarina Savikin; Gordana Zdunic; Teodora Jankovic; Tatjana Stanojkovic; Zorica Juranic; Nebojsa Menkovic
Journal:  Nat Prod Res       Date:  2009       Impact factor: 2.861

9.  Changes in glucose-6-phosphate dehydrogenase, copper, zinc-superoxide dismutase and catalase activities, glutathione and its metabolizing enzymes, and lipid peroxidation in rat erythrocytes with age.

Authors:  Oğuz Oztürk; Saadet Gümüşlü
Journal:  Exp Gerontol       Date:  2004-02       Impact factor: 4.032

10.  Assessment of the antiproliferative and apoptotic roles of sulfonamide carbonic anhydrase IX inhibitors in HeLa cancer cell line.

Authors:  Ismail Koyuncu; Ataman Gonel; Mustafa Durgun; Abdurrahim Kocyigit; Ozgur Yuksekdag; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.